Fulcrum Therapeutics, Inc. (FULC)
10.62
+0.48
(+4.68%)
USD |
NASDAQ |
Jan 20, 16:00
10.62
0.00 (0.00%)
After-Hours: 19:54
Fulcrum Therapeutics Market Cap: 574.47M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.555B |
| Biogen, Inc. | 24.24B |
| CorMedix, Inc. | 542.07M |
| Apellis Pharmaceuticals, Inc. | 2.590B |
| NovaBay Pharmaceuticals, Inc. | 825.37M |
Market Cap Related Metrics
| PEG Ratio | -0.0320 |
| Price to Book Value | 2.896 |
| Price | 10.62 |
| Earnings Yield | -11.11% |
| PEGY Ratio | -0.0320 |